In silico prediction of tyrosinase and adenylyl cyclase inhibitors from natural compounds

Natural Product Communications

Volumn 9, Issue 2, 2014, Pages 189-194

  Fong, Pedro ^a   Tong, Henry H Y ^a   Chao, Chi M ^a  

^a MACAO POLYTECHNIC INSTITUTE   (Macao)

Author keywords

Adenylyl cyclase; Computer aided drug discovery; Skin whitening; Tyrosinase

Indexed keywords

4 PHENETHYL 1,7 DIPHENYL 4 PHENETHYL 1,7 DIPHENYL 1 HEPTENE 3,5 DIONE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; ALPHA TOCOPHEROL; ARBUTIN; BELAMCANDOL A; CHRYSIN; DEHYDRO BETA TOCOPHEROL; DEPIGMENTING AGENT; DIA AURANTIAMIDE ACETATE; DIHYDROFERULIC ACID; DIHYDROFERULIC ACID[3 (4 HYDROXY 3 METHOXYPHENYL)PROPIONIC ACID]; FERULIC ACID; HERBACEOUS AGENT; KOJIC ACID; MELANIN; MONOPHENOL MONOOXYGENASE; NATURAL PRODUCT; OXYGENASE INHIBITOR; SHANCIOL B; TOCOPHEROL; TUSSILAGONE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARCINOGENESIS; COMPUTER MODEL; COMPUTER PROGRAM; CORROSION; CRYSTAL STRUCTURE; DRUG FORMULATION; DRUG PROTEIN BINDING; DRUG STABILITY; ENZYME INHIBITION; ENZYME STRUCTURE; HERB; MOLECULAR DOCKING; NONHUMAN; PHARMACOPHORE; SKIN IRRITATION; SKIN PERMEABILITY; SKIN PROTECTION; SKIN SENSITIZATION;

ADENYLATE CYCLASE; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; MONOPHENOL MONOOXYGENASE; PLANTS, MEDICINAL; SKIN LIGHTENING PREPARATIONS;

EID: 84894413698     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900214     Document Type: Article

References (49)

1. Slominski A, Tobin DJ, Shibahara S, Wortsman J. (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews, 84, 1155-1228. (Pubitemid 39287950)
2. Nakagawa M, Kawai K, Kawai K. (1995) Contact allergy to kojic acid in skin care products. Contact Dermatitis, 32, 9-13.
3. Wen AH, Choi MK, Kim DD. (2006) Formulation of liposome for topical delivery of arbutin. Archives of Pharmacal Research, 29, 1187-1192.
4. Draelos ZD. (2007) Skin lightening preparations and the hydroquinone controversy. Dermatologic Therapy, 20, 308-313.
5. Kim DC, Rho SH, Shin JC, Park HH, Kim D. (2011) Inhibition of melanogenesis by 5,7-dihydroxyflavone (chrysin) via blocking adenylyl cyclase activity. Biochemical and Biophysical Research Communications, 411, 121-125.
6. Dwivedi Y, Pandey GN. (2008) Adenylyl cyclase-cyclic AMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatric Disease and Treatment, 4, 161-176. (Pubitemid 351460987)
7. Newman DJ, Cragg GM. (2007) Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70, 461-477. (Pubitemid 46595760)
8. Gan LS, Yao W, Mo JX, Zhou CX. (2009) Alkaloids from Lindera aggregata. Natural Product Communications, 4, 43-46.
9. Fong P, Tong HH. (2012) In silico prediction of the cosmetic whitening effects of naturally occurring lead compounds. Natural Product Communications, 7, 1287-1294.
10. Chen CY. (2011) TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PloS One, 6, e15939.
11. Chang TS. (2009) An updated review of tyrosinase inhibitors. International Journal of Molecular Sciences, 10, 2440-2475.
12. Tajima R, Oozeki H, Muraoka S, Tanaka S, Motegi Y, Nihei H, Yamada Y, Masuoka N, Nihei K. (2011) Synthesis and evaluation of bibenzyl glycosides as potent tyrosinase inhibitors. European Journal of Medicinal Chemistry, 46, 1374-1381.
13. Misra BB, Dey S. (2013) TLC-bioautographic evaluation of in vitro anti-tyrosinase and anti-cholinesterase potentials of sandalwood oil. Natural Product Communications, 8, 253-256.
14. Hwan LD. (2010) Cosmetic compositions for skin whitening containing Sedum sarmentosum extract and arbutin. Patent Number: 42088632.
15. Song YL, Yan R, Jing WH, Zhao HY, Wang YT. (2011) Characterization of metabolism of (+)-praeruptorin B and (+)-praeruptorin E in human and rat liver microsomes by liquid chromatography coupled with ion trap mass spectrometry and time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry, 25, 719-730.
16. Leelapronpisid P, Leesawat P, Natakarnkitkul S, Rattanapanadda P. (2010) Application of chitosan for preparation of arbutin nanoparticles as skin whitening. Journal of Metals, Materials and Minerals, 20, 101-105.
17. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. (2007) Relating protein pharmacology by ligand chemistry. Nature Biotechnology, 25, 197-206. (Pubitemid 46227119)
18. Liu X, Ouyang S, Yu B, Liu Y, Huang K, Gong J, Zheng S, Li Z, Li H, Jiang H. (2010) PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Research, 38, W609-614.
19. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL. (2009) Predicting new molecular targets for known drugs. Nature, 462, 175-181.
20. Natsch A, Haupt T, Laue H. (2011) Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-kappaB signaling and are less sensitizing than S(N)Ar- and S(N)2- reactive chemicals. Chemical Research in Toxicology, 24, 2018-2027.
21. Wozniak D, Janda B, Kapusta I, Oleszek W, Matkowski A. (2010) Antimutagenic and anti-oxidant activities of isoflavonoids from Belamcanda chinensis (L.) DC. Mutation Research, 696, 148-153.
22. Chen KC, Sun MF, Yang SC, Chang SS, Chen HY, Tsai FJ, Chen CY. (2011) Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology & Drug Design, 78, 679-688.
23. Suhas R, Channe Gowda D. (2012) Structure-based rationale design and synthesis of aurantiamide acetate analogues - towards a new class of potent analgesic and anti-inflammatory agents. Chemical Biology & Drug Design, 79, 850-862.
24. Ng TB, Liu F, Lu Y, Cheng CH, Wang Z. (2003) Antioxidant activity of compounds from the medicinal herb Aster tataricus. Comparative Biochemistry and Physiology - Part C: Toxicology & Pharmacology, 136, 109-115. (Pubitemid 37237545)
25. Schagen SK, Zampeli VA, Makrantonaki E, Zouboulis CC. (2012) Discovering the link between nutrition and skin aging. Dermato-endocrinology, 4, 298-307.
26. Oresajo C, Stephens T, Hino PD, Law RM, Yatskayer M, Foltis P, Pillai S, Pinnell SR. (2008) Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin. Journal of Cosmetic Dermatology, 7, 290-297.
27. Kosari P, Alikhan A, Sockolov M, Feldman SR. (2010) Vitamin E and allergic contact dermatitis. Dermatitis, 21, 148-153.
28. Hwangbo C, Lee HS, Park J, Choe J, Lee JH. (2009) The anti-inflammatory effect of tussilagone, from Tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages. International Immunopharmacology, 9, 1578-1584.
29. Huang HC, Chiu SH, Chang TM. (2011) Inhibitory effect of [6]-gingerol on melanogenesis in B16F10 melanoma cells and a possible mechanism of action. Bioscience, Biotechnology, and Biochemistry, 75, 1067-1072.
30. Kuhn M, Szklarczyk D, Franceschini A, von Mering C, Jensen LJ, Bork P. (2011) STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Research, 40, D876-880.
31. Lee YM, Kang SM, Chung JH. (2011) The role of TRPV1 channel in aged human skin. Journal of Dermatological Science, 65, 81-85.
32. Jain AN. (2007) Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. Journal of Computer-Aided Molecular Design, 21, 281-306.
33. Baek HS, Hong YD, Lee CS, Rho HS, Shin SS, Park YH, Joo YH. (2012) Adamantyl N-benzylbenzamide: new series of depigmentation agents with tyrosinase inhibitory activity. Bioorganic & Medicinal Chemistry Letters, 22, 2110-2113.
34. Thanigaimalai P, Lee KC, Sharma VK, Joo C, Cho WJ, Roh E, Kim Y, Jung SH. (2011) Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase. Bioorganic & Medicinal Chemistry Letters, 21, 6824-6828.
35. Cho JC, Rho HS, Baek HS, Ahn SM, Woo BY, Hong YD, Cheon JW, Heo JM, Shin SS, Park YH, Suh KD. (2012) Depigmenting activity of new kojic acid derivative obtained as a side product in the synthesis of cinnamate of kojic acid. Bioorganic & Medicinal Chemistry Letters, 22, 2004-2007.
36. Pieper U, Eswar N, Webb BM, Eramian D, Kelly L, Barkan DT, Carter H, Mankoo P, Karchin R, Marti-Renom MA, Davis FP, Sali A. (2009) MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Research, 37, D347-354.
37. Mou TC, Gille A, Fancy DA, Seifert R, Sprang SR. (2005) Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-triphosphate. The Journal of Biological Chemistry, 280, 7253-7261. (Pubitemid 40341283)
38. Steegborn C, Litvin TN, Hess KC, Capper AB, Taussig R, Buck J, Levin LR, Wu H. (2005) A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen. The Journal of Biological Chemistry, 280, 31754-31759. (Pubitemid 41291924)
39. Clark M, Cramer RD, Opdenbosch NV. (1989) Validation of the general purpose tripos 5.2 force field. Journal of Computational Chemistry, 10, 982-1012.
40. Wallace AC, Laskowski RA, Thornton JM. (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, 8, 127-134.
41. The PyMOL Molecular Graphics System VS, LLC.
42. Walker JD, Gerner I, Hulzebos E, Schlegel K. (2005) The Skin Irritation Corrosion Rules Estimation Tool (SICRET) QSAR & Combinatorial Science, 24, 378-384. (Pubitemid 40637939)
43. Enoch SJ, Madden JC, Cronin MT. (2008) Identification of mechanisms of toxic action for skin sensitization using a SMARTS pattern based approach. SAR and QSAR in Environmental Research, 19, 555-578.
44. Roberts DW, Aptula AO, Patlewicz G. (2006) Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chemical Research in Toxicology, 19, 1228-1233. (Pubitemid 44454040)
45. Benigni R, Bossa C, Jeliazkova N, Netzeva T, Worth A. The Benigni / Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree European Commission Report EUR 23241 EN,
46. Enoch SJ, Hewitt M, Cronin MT, Azam S, Madden JC. (2008) Classification of chemicals according to mechanism of aquatic toxicity: an evaluation of the implementation of the Verhaar scheme in Toxtree. Chemosphere, 73, 243-248.
47. Potts RO, Mak VH, Guy RH, Francoeur ML. (1991) Strategies to enhance permeability via stratum corneum lipid pathways. Advances in Lipid Research, 24, 173-210.
48. Overington JP, Al-Lazikani B, Hopkins L. (2006) How many drug targets are there? Nature Reviews, 5, 993-996. (Pubitemid 44835126)
49. Liu H, Wang J, Zhou W, Wang Y, Yang L. (2013) Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice. Journal of Ethnopharmacology, 146, 773-793.